OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
Alexander A. Berezin, I. M. Fushtey, Alexander Е. Berezin
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 1, pp. 23-23
Open Access | Times Cited: 5
Alexander A. Berezin, I. M. Fushtey, Alexander Е. Berezin
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 1, pp. 23-23
Open Access | Times Cited: 5
Showing 5 citing articles:
Circulating Myokines as Novel Biomarkers for Cardiovascular Diseases
Jin-xiu Lyu, Dandan Guo, Yu-Chen Song, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 2, pp. 56-56
Open Access | Times Cited: 4
Jin-xiu Lyu, Dandan Guo, Yu-Chen Song, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 2, pp. 56-56
Open Access | Times Cited: 4
The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications
Xiaohui Duan, Xiaomeng Zhang, Bao Sun
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Xiaohui Duan, Xiaomeng Zhang, Bao Sun
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Methods to predict heart failure in diabetes patients
Alexander Е. Berezin, Tetiana A. Berezina, Uta C. Hoppe, et al.
Expert Review of Endocrinology & Metabolism (2024) Vol. 19, Iss. 3, pp. 241-256
Closed Access | Times Cited: 2
Alexander Е. Berezin, Tetiana A. Berezina, Uta C. Hoppe, et al.
Expert Review of Endocrinology & Metabolism (2024) Vol. 19, Iss. 3, pp. 241-256
Closed Access | Times Cited: 2
Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure
Alexander A. Berezin, Zeljko Obradovic, Ye. V. Novikov, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 2940-2940
Open Access | Times Cited: 10
Alexander A. Berezin, Zeljko Obradovic, Ye. V. Novikov, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 2940-2940
Open Access | Times Cited: 10
Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure
Tetiana A. Berezina, I. M. Fushtey, Alexander A. Berezin, et al.
Advances in Therapy (2023) Vol. 41, Iss. 1, pp. 292-314
Open Access | Times Cited: 6
Tetiana A. Berezina, I. M. Fushtey, Alexander A. Berezin, et al.
Advances in Therapy (2023) Vol. 41, Iss. 1, pp. 292-314
Open Access | Times Cited: 6
Effects of dapagliflozin on cardiac function indexes and serum MCP-1 levels in patients with Type 2 diabetes mellitus complicated with heart failure
Xianpei Zhang, Yang Yang‐Hartwich, Weizhe Xiao, et al.
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 4, pp. 3963-3975
Closed Access
Xianpei Zhang, Yang Yang‐Hartwich, Weizhe Xiao, et al.
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 4, pp. 3963-3975
Closed Access
